Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morgan Keegan & Company was a prominent American investment bank and wealth management firm headquartered in Memphis, Tennessee. Founded in 1969, the firm established a significant presence in the healthcare and life sciences sectors through its specialized investment banking and equity research teams. The company provided capital raising, M&A advisory, and strategic consulting services to a wide array of biotechnology, medical technology, and healthcare service providers. In 2012, Morgan Keegan was acquired by Raymond James Financial for approximately $1.2 billion, a move that significantly expanded Raymond James' footprint in the fixed income and public finance markets. Following the acquisition, Morgan Keegan's operations were integrated into the Raymond James brand, concluding its tenure as an independent entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morgan Keegan.